The European Medicines Agency’s Committee for Medicinal Products for Human recommends eight new medicines for approval, alongside 13 extensions of indication for existing medicines. Among the...
The EMA’s April meeting of the Medicinal Products for Human Use Committee (CHMP) recommended five new medicines and nine existing medicines with extended therapeutic indications for...
A dispute between Médecins Sans Frontières (MSF) and Gilead Sciences has entered the public domain after the pharma company refused to sell its game-changing HIV-prevention medicine...
The European Medicines Agency (EMA) has recommended five new medicines for approval following its Committee for Medicinal Products for Human Use (CHMP) meeting in March 2026,...
